Bionomics Limited is a biotechnology company focused on developing innovative therapeutic solutions for various neurological and psychiatric disorders

The company leverages its proprietary drug discovery platform to identify and advance novel compounds that can address unmet medical needs in areas such as anxiety, depression, and cognitive dysfunction. With a strong commitment to research and development, Bionomics collaborates with academic institutions and industry partners to bring new treatments to clinical trials, aiming to improve the quality of life for patients facing challenging mental health conditions.